Whisper · NRI Repatriation Intelligence · Ireland

CEO Jobs in India for NRIs in Ireland

Whisper is the discreet CEO job intelligence platform from Gladwin International — encrypted mandate flow for India’s senior leaders, surfaced 60–90 days before public.

For an Indian-origin Dublin, Cork, or Galway-resident senior executive, returning to a CEO seat in India is a 9-12 month playbook driven by three simultaneous variables: the Dublin EU HQ / Cork-pharma / Apple-Cork credential framing, the CSEP → Stamp 4 → citizenship sequencing, and the India-Ireland Strategic Partnership 2023 tailwind. Dublin hosts the densest FAANG / Fortune-100 EU HQ cluster outside the US west coast — making it the most-structured parent-region rotation source for India MD seats in Europe.

~50K
Indian diaspora — Dublin (Silicon Docks IFSC), Cork (pharma), Galway (medtech); growing fast
22+
Active CEO mandates explicitly seeking Ireland-resident returnees per quarter
~10-15%
Indian-origin share of Dublin tech-senior workforce at Google / Meta / LinkedIn EU HQs
21 months
CSEP → Stamp 4 PR fast-track — faster than Germany Blue Card or UK Skilled Worker

01 · The Dublin–Bangalore corridor

Dublin hosts the densest FAANG / Fortune-100 EU HQ cluster outside the US west coast

The Indian-origin senior-leader bench in Ireland is approximately 50,000 strong — small in absolute terms versus US (4M), UAE (3.5M), Saudi Arabia (2.6M), but growing fast and the most tech-dense + pharma-dense NRI corridor outside the US-Anglosphere cluster. The bench concentrates around three metros: Dublin (corporate-administrative anchor — Silicon Docks IFSC tech cluster hosting Google EU HQ, Meta EU HQ, LinkedIn EU HQ, Microsoft Sandyford, Salesforce, Workday, Stripe headquarters; plus Accenture Dublin one of Accenture's biggest global offices, AIB and Bank of Ireland — densest Indian residential clusters in Sandyford, Tallaght, Lucan, Adamstown), Cork (pharma corridor — Pfizer Cork manufacturing, Eli Lilly Kinsale, AbbVie Cork, Apple Cork — Apple Operations Europe HQ + manufacturing), and Galway (medtech corridor — Medtronic Galway, Boston Scientific Galway). Indian boards actively recruit from this cohort for ~22 active CEO mandates per quarter, with distinct sectoral concentration in FAANG India MD rotations, pharma India MDs, medtech India MDs, fintech CEO seats, and Indian consulting partner-leadership bench.

The Ireland→India corridor differs from UK, Germany, US, and APAC corridors in four structural dimensions. First, Dublin EU HQ density — Dublin hosts the EU HQs of Google (~9,000 employees, second-biggest Google office globally), Meta (~6,000), LinkedIn, Microsoft, Salesforce, Workday, plus Stripe-headquartered (founded by Irish Collison brothers). An estimated 10-15% of Indian-origin Dublin tech workforce holds senior product / engineering / management roles at these EU HQs. No other European city has comparable FAANG / Fortune-100 EU HQ density. Dublin/Cork acts as parent-region rotation source for India MD seats. Second, Cork pharma + Galway medtech cluster — Cork (Pfizer's largest manufacturing site outside US, Eli Lilly Kinsale — second-largest Lilly facility globally, AbbVie Cork) + Galway (Medtronic — largest Medtronic R&D + manufacturing globally outside US, Boston Scientific Galway) form Europe's densest pharma + medtech manufacturing cluster.

Third, Critical Skills Employment Permit (CSEP) + Stamp 4 PR fast-track — Ireland's CSEP provides no-labour-market-test access for tech / pharma senior leaders at salaries above €38K, Stamp 4 PR after 21 months on CSEP (faster than Germany Blue Card's 33-month route or UK Skilled Worker's 5-year route), and Irish citizenship after 5 years total residency. Irish passport on naturalization yields EU citizenship. This is structurally the most- flexible EU work-visa-to-PR pathway. Fourth, tax — progressive 20-40% income tax + USC effective ~48-52% top marginal rate (the 12.5% Irish corporate tax that draws MNC EU HQs is unrelated to personal-tax treatment). India comp becomes moderately competitive post-tax for senior seats — structurally similar to Japan corridor but less extreme. India-Ireland Strategic Partnership 2023 has formalised bilateral cooperation across education, tech, pharma, R&D, and senior-leadership mobility.

02 · Dublin EU HQ rotation pipeline

Six FAANG / Fortune-100 EU HQs — six distinctive India MD rotation pathways

Dublin's EU HQ density creates the most-structured parent-region rotation source for India MD seats in Europe. Google Dublin EU HQ (~9,000 employees), Meta Dublin EU HQ (~6,000), LinkedIn Dublin EU HQ, Microsoft Dublin Sandyford, Salesforce Dublin, Stripe Dublin HQ — all maintain explicit India MD rotation programs with Dublin/Cork acting as parent-region rotation source for India MD seats at FAANG and Fortune-100 captives. Senior Indian-origin product / engineering / programme-management directors at Dublin EU HQ typically rotate to India MD bench on 2-3 year horizons. The table below documents six Dublin parent EU HQs with their India destination bench and rotation pattern.

Dublin EU HQ rotation pipeline · FAANG / Fortune-100 captive → India MD seat
Dublin Parent / EU HQScopeDublin ArchetypeIndia Seat BenchRotation Pattern
Google Dublin EU HQ (Silicon Docks)~9,000 employees — second-biggest Google office globally; EMEA HQ + product / engineering / partnerships / salesSenior product / engineering / programme-management director at Google DublinGoogle India MD (Bangalore / Gurgaon HQ); Google India Cloud / Google India Pay / Google India Search platform-CEO benchDublin EU HQ → India MD bench (2-3 year horizon); India MD typically rotated to / from Dublin or Mountain View
Meta Dublin EU HQ (Silicon Docks)~6,000 employees — EMEA HQ + product / engineering / partner development / sales / trust & safetySenior product / engineering / partner-development director at Meta DublinMeta India MD (Mumbai / Bangalore HQ); Instagram India / WhatsApp India / Threads India platform-leadership benchDublin EU HQ → India MD bench (2-3 year horizon); India MD typically rotated to / from Dublin or Menlo Park
LinkedIn Dublin EU HQEMEA HQ at Silicon Docks; product / engineering / marketing / sales / customer successSenior product / sales / customer-success director at LinkedIn DublinLinkedIn India MD (Bangalore HQ); LinkedIn India Sales / Talent Solutions / Marketing Solutions platform-leadershipDublin EU HQ → India MD bench (2-3 year horizon); rotation cycles tied to LinkedIn parent Microsoft cadence
Microsoft Dublin (Sandyford)EMEA operations + Office 365 EMEA + Azure EMEA + customer-success + LinkedIn integrationSenior product / customer-success / cloud-engineering director at Microsoft DublinMicrosoft India MD (Bangalore / Hyderabad HQ); Microsoft India Cloud / Azure India / Office India platform-CEO benchDublin EU HQ → India MD bench (2-3 year horizon); India MD typically rotated to / from Redmond or Dublin
Salesforce Dublin EU HQEMEA HQ + product / engineering / customer-success / sales / Trailhead India-interfaceSenior product / customer-success / sales director at Salesforce DublinSalesforce India MD (Bangalore HQ); Salesforce India platform-leadership benchDublin EU HQ → India MD bench (2-3 year horizon); rotation cycles tied to Salesforce SF parent cadence
Stripe Dublin HQ (Stripe Ireland)Stripe-headquartered in Dublin — founded by Irish Collison brothers; product / engineering / India-interfaceSenior product / engineering director at Stripe Dublin with India-interface responsibilityStripe India CEO (payments-infrastructure operations); Indian fintech CEO at adjacent platforms (Razorpay, PhonePe, Decentro)Dublin HQ → India CEO bench at Stripe India or adjacent Indian fintech platforms (1-2 year horizon, high-prestige)
Dublin hosts the EU HQs of Google, Meta, LinkedIn, Microsoft, Salesforce, Workday, and Stripe — an estimated 10-15% of Indian-origin Dublin tech workforce holds senior product / engineering / management roles. Dublin/Cork acts as parent-region rotation source for India MD seats at FAANG and Fortune-100 captives.

03 · Cork pharma + Galway medtech corridor

Europe's densest pharma + medtech manufacturing cluster — distinctive India MD bench

Cork pharma cluster (Pfizer Cork — Pfizer's largest manufacturing site outside US, Eli Lilly Kinsale — second-largest Lilly manufacturing globally, AbbVie Cork) + Galway medtech cluster (Medtronic Galway — largest Medtronic R&D + manufacturing globally outside US, Boston Scientific Galway) + Apple Cork (Apple Operations Europe — Apple's largest non-US office in EMEA) form a distinctive Ireland-pharma-medtech-services corridor. Senior Indian-origin commercial and operating leadership at Cork pharma facilities is routinely placed at Pfizer India MD, Eli Lilly India MD, AbbVie India MD, plus Indian listed-pharma CEO seats (Sun, Dr Reddy's, Cipla, Lupin, Aurobindo, Glenmark). Galway medtech leadership translates to Medtronic India MD, Boston Scientific India MD, plus Indian listed-medtech. The table below documents six Cork / Galway entities with their Indian destination bench.

Cork pharma + Galway medtech + Apple Cork · India MD bench translation
Cork / Galway ParentScopeCork-Galway ArchetypeIndia Bench DestinationMandate Density
Pfizer CorkLargest Pfizer manufacturing site outside the US; sterile injectable + active-ingredient (API) + finished-dose manufacturingPlant President / EVP Operations / Senior Commercial Director at Pfizer CorkPfizer India MD, Indian listed-pharma CEO bench (Sun Pharma, Dr Reddy's, Cipla, Lupin, Aurobindo, Glenmark)~2 active India seats per quarter at Pfizer India + adjacent listed-pharma CEO tier
Eli Lilly Cork (Kinsale)Active-ingredient manufacturing site; second-largest Lilly manufacturing facility globally; oncology + diabetes pipelinePlant President / EVP Operations / Senior R&D Director at Lilly CorkEli Lilly India MD, Indian listed-pharma CEO bench (Sun Pharma, Dr Reddy's, Cipla, Lupin)~2 active India seats per quarter at Lilly India + adjacent listed-pharma CEO tier
AbbVie CorkLarge AbbVie manufacturing site; immunology + oncology API + finished-dose manufacturingPlant President / EVP Operations / Senior Commercial Director at AbbVie CorkAbbVie India MD, Indian listed-pharma CEO bench (Sun Pharma, Cipla, Lupin, Aurobindo)~1-2 active India seats per quarter at AbbVie India + adjacent listed-pharma CEO tier
Medtronic GalwayLargest Medtronic R&D and manufacturing site globally outside US; cardiovascular + diabetes + spine medical devicesSenior R&D Director / EVP Operations / Senior Commercial Director at Medtronic GalwayMedtronic India MD, Indian listed-medtech bench (Poly Medicure, Healthium, Skanray), MNC medtech India~1-2 active India seats per quarter at Medtronic India + adjacent listed-medtech CEO tier
Boston Scientific GalwayLarge Boston Scientific R&D and manufacturing site; cardiovascular + urology + endoscopy medical devicesSenior R&D Director / EVP Operations / Senior Commercial Director at Boston Scientific GalwayBoston Scientific India MD, Indian listed-medtech CEO bench, MNC medtech India MD pathways~1 active India seat per quarter at Boston Scientific India + adjacent listed-medtech CEO tier
Apple Cork (Apple Operations Europe)~6,000 employees — Apple's largest non-US office in EMEA; manufacturing + EU services HQ + finance / supply-chain operationsSenior operations / services / supply-chain director at Apple Cork (Apple Operations Europe)Apple India Country MD, Apple India services / retail / supply-chain platform-CEO bench~1 active India seat per quarter at Apple India Country MD tier (high-prestige seat)
Cork (pharma) + Galway (medtech) + Apple Cork (services/manufacturing) form a distinctive Ireland-pharma-medtech corridor — Cork-anchored senior Indian-origin operating leadership has clean parent-Cork→India-MD translation pathways at Pfizer India, Lilly India, AbbVie India, Medtronic India, Boston Scientific India, and Apple India Country MD seats.

04 · Live signal

NRI-Ireland repatriation signals — last 90 days

Live signals relevant to an Indian-origin Ireland-resident executive planning the return — Google / Meta / LinkedIn / Microsoft Dublin EU HQ India MD rotations, Cork pharma India platform transitions, Apple Cork → Apple India Country MD moves, Stripe India payments- infrastructure CEO mandates, Medtronic / Boston Scientific Galway India MD transitions, CSEP / Stamp 4 regulatory updates, and India-Ireland Strategic Partnership 2023 anniversary cycles.

Live · NRI-Ireland repatriation signals · last 90 days · Dublin EU-HQ + Cork pharma scope
  • 29 Apr 2026
    Google Dublin
    Google India · MD designate confirmed — ex-Google Dublin EU HQ senior product director
    Google Dublin EU HQ (~9,000 employees, second-biggest Google office globally) is the largest single Ireland→India MD rotation pipeline. Senior Indian-origin product / engineering / programme-management leaders rotate to Google India MD at Bangalore / Gurgaon HQs. Distinctive Silicon Docks IFSC corridor.
  • 21 Apr 2026
    Meta Dublin
    Meta India · MD India bench transition — ex-Meta Dublin EU HQ product-marketing director
    Meta (Facebook) Dublin EU HQ (~6,000 employees) feeds Meta India MD seat at Mumbai / Bangalore. Senior Indian-origin product-marketing, engineering, and partner-development leaders at Dublin's Silicon Docks are top-shortlisted for India MD succession.
  • 14 Apr 2026
    Cork Pharma
    Pfizer India · MD designate confirmed — ex-Pfizer Cork senior commercial lead
    Cork pharma corridor (Pfizer / Eli Lilly / AbbVie / Medtronic) is one of the most-active Ireland→India MD pathways. Senior Indian-origin commercial and operating leaders at Cork pharma manufacturing facilities are routinely placed at Indian listed-pharma and MNC pharma India MD seats.
  • 03 Apr 2026
    Stripe India
    Stripe India · India payments-infra CEO search active — Dublin HQ rotation candidate preferred
    Stripe (Dublin-headquartered, founded by Irish Collison brothers) India payments-infrastructure operations is an emerging high-priority CEO mandate. Indian fintech regulatory complexity vs Stripe's Dublin product-ops sophistication creates distinctive India CEO opportunity.
  • 25 Mar 2026
    Apple Cork
    Apple India · Country MD search — ex-Apple Cork senior operations leader confirmed
    Apple Cork (~6,000 employees — manufacturing + EU services HQ for Apple) is one of Apple's largest non-US offices globally. Senior Indian-origin operations and services-leadership at Apple Cork are highly competitive for Apple India Country MD seat — most-direct Apple-Cork→Apple-India pathway.
  • 15 Mar 2026
    CSEP Update
    DETE Ireland · Critical Skills Employment Permit (CSEP) updates for 2026 cohort
    Critical Skills Employment Permit (CSEP) provides fast-track tech / pharma senior-leader access — no labour-market test for salaries above €38K, Stamp 4 PR after 21 months on CSEP (faster than Germany / UK), citizenship after 5 years total residency.
  • 05 Mar 2026
    India-Ireland
    Embassy of India Dublin · India-Ireland Strategic Partnership 2023 anniversary summit
    India-Ireland Strategic Partnership 2023 anniversary is generating distinctive bilateral senior-leadership mobility programs. Indian Embassy Dublin actively coordinates India-Ireland tech mobility — distinctive corridor culture for India-return planning.
  • 25 Feb 2026
    Medtronic Galway
    Medtronic India · MD India designate confirmed — ex-Medtronic Galway senior R&D leader
    Galway medtech cluster (Medtronic / Boston Scientific) is the second-largest Ireland-pharma-medtech rotation pipeline after Cork. Senior Indian-origin R&D and operating leaders at Galway medtech facilities are routinely placed at Indian listed-medtech and MNC medtech India MD seats.
Sample of 8. Whisper Infinity Plus members in the Ireland corridor receive the full feed (typically 16–22 IE→India CEO signals per quarter), the named retained firms running Dublin–Bangalore / Cork–Mumbai mandates, and a personalised CSEP → Stamp 4 → India MD timing brief.

05 · The playbook

The 9-12 month pre-positioning sequence calibrated to Dublin EU HQ rotation cycles

Dublin EU HQ rotation cycles operate on 6-18 month internal nemawashi timelines. CSEP → Stamp 4 → citizenship pathway provides flexible reverse-mobility insurance. The 9-12 month window is calibrated to both.

Months 1-3 — informal trust-build. India-Ireland Business Association and FICCI / CII Ireland-chapter event participation. Embassy of India Dublin industry-engagement calendar. India-Ireland Strategic Partnership 2023 anniversary cycle programs. Deliberate India business-travel cadence — Mumbai BKC, Bangalore, Hyderabad industry visits. Dublin tech-community internal networking — Web Summit Dublin events, Inspire Fest, Dogpatch Labs community programs. Board-interlock mapping for target Indian listed and family-business groups. Discreet verbal-only conversations with 2-3 retained search firms running active Ireland-targeted Indian mandates — Egon Zehnder Dublin / London, Spencer Stuart Dublin / London, Heidrick Dublin, Korn Ferry Dublin, plus India-only retained firms with Dublin-corridor scope.

Months 4-7 — active mandate exploration. Whisper-coordinated mandate flow against pre-defined comp / sector / geo envelope. Dublin EU HQ / Cork-pharma / Apple-Cork / Stripe credential framing for Indian board context. EUR-Irish-taxed vs INR-taxed arithmetic calibrated against target Indian offer tier with ESOP / long-cycle-equity overlay (post-tax India advantage moderate at lower Indian-offer thresholds). Internal Dublin EU HQ consensus-build for India MD rotation — typical Dublin EU HQ internal rotation-cycle alignment is 6-18 months. 2-3 specific mandates surfaced for active consideration with named hiring authorities and named retained firms.

Months 8-12 — Dublin EU HQ exit + family relocation. Dublin EU HQ internal rotation-cycle-aligned exit timing. Stamp 4 / Irish-citizenship status decision (preserve for reverse-mobility insurance vs full-exit). DETE Ireland exit clearance. Tax-residency status calibration during the India-return year — Irish tax law treats taxable income for residents on standard EU framework. Indian international school admission decisions (April-March academic year, typically closing November of prior year). Healthcare provider transitions in target Indian metro. NRE/NRO setup and EUR-to-INR remittance optimisation routed during the 2-year RNOR window for full Indian-tax exemption. Final mandate negotiation with hiring authority — comp, equity, board access, relocation terms.

The Stamp 4 / citizenship optionality lever: Senior Ireland-resident executives weighing apex-tier Indian CEO seats with Ireland advisory-only retention have meaningfully more flexibility than US H-1B or Germany Blue Card peers. Stamp 4 PR permits multi-month India absence with periodic re-entry, and Irish citizenship (after 5 years total residency) yields EU passport with multi-decade base-retention optionality. The structural caveat: Indian boards still filter for genuine return commitment at full-time CEO tier, so Stamp 4 / Irish-citizenship-based partial- return arrangements work best for advisory / board / non-executive engagements, not full-time CEO seats.

06 · Eight archetypes

The Ireland returnee → India CEO archetype map — by sub-sector

Ireland→India returnees split across eight archetypal pathways. Dublin EU HQ FAANG / Fortune- 100 captives is the largest single cluster (~8 active mandates per quarter); Cork pharma is the most-structured pharma rotation corridor; Galway medtech is the most-distinctive medtech corridor; Apple Cork is the highest-prestige India Country MD pathway. The cards below document the typical Ireland background, the typical Indian destination, and mandate-flow density across each.

Google / Meta / LinkedIn / Microsoft Dublin EU HQ → FAANG India MD

~8 active mandates

Background: Senior product / engineering / programme-management director at Dublin EU HQ → FAANG India MD seat

The single largest Ireland→India CEO corridor. Google Dublin EU HQ (~9,000), Meta Dublin EU HQ (~6,000), LinkedIn Dublin EU HQ, Microsoft Dublin Sandyford, Salesforce Dublin — Dublin acts as parent-region rotation source for India MD seats at FAANG and Fortune-100 captives. Estimated 10-15% of Indian-origin Dublin tech workforce holds senior management roles at these EU HQs.

Cork Pharma (Pfizer / Lilly / AbbVie) → Indian Listed Pharma CEO

~6 active mandates

Background: Plant President / EVP / Senior Commercial Director at Cork pharma → Indian listed-pharma CEO bench

Cork pharma cluster (Pfizer Cork — Pfizer's largest manufacturing site outside US, Eli Lilly Kinsale — second-largest Lilly facility globally, AbbVie Cork) is one of the most-active Ireland→India MD pathways. Senior Indian-origin commercial and operating leaders at Cork pharma manufacturing facilities are routinely placed at Pfizer India MD, Lilly India MD, AbbVie India MD, plus Indian listed-pharma CEO seats (Sun, Dr Reddy's, Cipla, Lupin, Aurobindo).

Galway Medtech (Medtronic / Boston Scientific) → Indian Medtech CEO

~3 active mandates

Background: Senior R&D Director / EVP at Medtronic Galway / Boston Scientific Galway → Indian medtech India MD

Galway medtech cluster (Medtronic — largest Medtronic R&D + manufacturing site globally outside US, Boston Scientific Galway) is the second-largest Ireland-pharma-medtech rotation pipeline after Cork. Medtronic India MD, Boston Scientific India MD seats — both with explicit Galway parent rotation. Indian listed-medtech (Poly Medicure, Healthium, Skanray) also actively recruit.

Apple Cork → Apple India Country MD

~2 active mandates

Background: Senior operations / services / supply-chain director at Apple Cork → Apple India Country MD

Apple Cork (~6,000 employees — Apple's largest non-US office in EMEA, manufacturing + EU services HQ) creates the most-direct Apple-Cork→Apple-India pathway. Senior Indian-origin operations and services-leadership at Apple Cork are highly competitive for Apple India Country MD seat — one of the most high-prestige India MD seats in the market.

Stripe Dublin → Stripe India / Indian Fintech CEO

~2 active mandates

Background: Senior product / engineering director at Stripe Dublin → Stripe India CEO / Indian fintech CEO

Stripe (Dublin-headquartered, founded by Irish Collison brothers) India payments-infrastructure operations is an emerging high-priority CEO mandate. Indian fintech regulatory complexity vs Stripe's Dublin product-ops sophistication creates distinctive India CEO opportunity. Adjacent Indian fintech (Razorpay, PhonePe, BharatPe, Decentro) also recruit Stripe Dublin senior bench.

Intel Leixlip → Indian Semicon / PLI-cohort CEO

~2 active mandates

Background: Senior fab-engineering / operations director at Intel Leixlip (wafer fab) → Indian semicon-mission CEO

Intel Ireland Leixlip wafer fab is one of Europe's largest semiconductor manufacturing facilities. Senior Indian-origin fab-engineering and operations leadership at Leixlip is highly competitive for India semiconductor mission-driven mandates — Tata-PSMC, Vedanta-Foxconn, Kaynes Tech, Tower Semiconductor India, and Indian listed-semicon platform CEO seats.

Accenture Dublin → Accenture India + Indian Consulting Leadership

~3 active mandates

Background: Senior MD / Partner at Accenture Dublin (one of Accenture's largest global offices) → Accenture India leadership / Indian consulting CEO

Accenture Dublin is one of Accenture's biggest global offices with ~1,500 partners. Senior Indian-origin partner-track leadership at Accenture Dublin rotates to Accenture India MD and partner-leadership bench. Adjacent Big-4 consulting India (Deloitte India, EY India, KPMG India, PwC India) also recruit Dublin senior bench.

Irish-Indian Tech Founder Returnees → Indian Unicorn CEO

~2 active mandates

Background: Founder / senior product leader at Irish startup → Indian unicorn CEO at Bangalore / Mumbai

Distinctive emerging corridor. Irish-Indian tech founders building India platforms (frequently with Dublin-built product / engineering foundations) are increasingly returning to Bangalore / Mumbai to scale India-market operations. Distinctive entrepreneurial-credential corridor.

07 · Adjacent intelligence

By geography & specialisation

Ireland→India mandate flow concentrates in Bangalore (FAANG India MDs, Google / Meta / LinkedIn / Microsoft India captive HQs, India tech-platform CEOs), Mumbai (Apple India Country MD, Stripe India, pharma India MDs), and Hyderabad (pharma India MDs, Cork-Hyderabad pharma corridor cluster). Continue with the geography or specialty most aligned to your Ireland background.

How Whisper Works

From the day you activate to the day you sign — the Whisper journey, decoded.

Whisper is not a job board, not a recruiter, not a public profile. It is a private intelligence agent that observes the apex of your market on your behalf — and decodes what it sees against your criteria, your discretion limits, and your timeline. Five steps from membership activation to a closed mandate.

  1. 01

    Activate

    Choose annual or monthly membership and complete payment via Razorpay. Within minutes you are inside the Whisper portal, with your encrypted delivery channel — Email, Signal, or in-portal — configured to your preference.

  2. 02

    Calibrate

    Upload your CV and set the mandate criteria that matter — sectors, geographies, compensation floor, governance posture, conviction threshold. Whisper trains your dedicated agent on your profile, your filters, and your discretion limits.

  3. 03

    Receive

    Bi-weekly briefings arrive at your channel of choice. Each carries 6–10 high-conviction signals — sourced, timestamped, and decoded against your criteria. No noise, no inbound applications, no public footprint.

  4. 04

    Engage

    Each briefing carries pre-drafted reach-outs calibrated to the recipient — board-direct, peer-to-peer, governance-aware. Whisper drafts; you approve; you send. Nothing leaves on your behalf without your explicit instruction.

  5. 05

    Land

    You pursue what fits, decline what doesn't, and close on your terms. Your existence in the Whisper system stays invisible to recruiters, search firms, and platforms — throughout the search, and beyond.

Three tiers · Annual or monthly · All self-serve

See the membership plan calibrated to where you sit and the market you scan.

See Membership Plans

08 · Membership

Three ways to access the Indian CEO market from an Ireland base

Ireland-resident NRIs default to Infinity Plus — explicitly built around the cross-border use case (Dublin EU HQ / Cork-pharma / Apple-Cork credential framing, CSEP → Stamp 4 → citizenship sequencing, EUR-INR post-tax modelling, Dublin EU HQ rotation-cycle alignment briefings, FAANG India MD pipeline mandate flow, India-Ireland Strategic Partnership tailwind positioning). Magnus is for NRIs already substantially returned (sub-1-year Ireland ties remaining). Apex Club is calibrated to Group-CEO and Country-CEO mandates at Indian listed-large-cap, FAANG India MD apex tier (Google India / Apple India Country MD bench), and Indian listed-pharma Group-CEO succession — the diaspora-targeted seats at the very top of the Ireland corridor.

Monthly subscription · billed monthly via Razorpay

09 · Questions

Frequently asked — Ireland-to-India CEO repatriation

How is the Ireland NRI corridor different from UK, Germany, or US corridors?

Four structural differences. (1) Dublin EU HQ density — Dublin hosts the EU HQs of Google (~9,000 employees, second-biggest Google office globally), Meta (~6,000), LinkedIn, Microsoft, Salesforce, Workday, plus Stripe-headquartered. An estimated 10-15% of Indian-origin Dublin tech workforce holds senior product / engineering / management roles at these EU HQs. No other European city has comparable FAANG / Fortune-100 EU HQ density. Dublin/Cork acts as parent-region rotation source for India MD seats. (2) Cork pharma + Galway medtech cluster — Cork (Pfizer's largest manufacturing site outside US, Eli Lilly Kinsale — second-largest Lilly facility globally, AbbVie Cork) + Galway (Medtronic — largest Medtronic R&D + manufacturing globally outside US, Boston Scientific Galway) form Europe's densest pharma + medtech manufacturing cluster. Distinctive India MD bench pathway. (3) Critical Skills Employment Permit (CSEP) + Stamp 4 PR fast-track — no labour-market test for salaries above €38K, Stamp 4 PR after 21 months on CSEP (faster than Germany / UK 5-year cycles), citizenship after 5 years total residency. EU passport on naturalization. (4) Tax — 20-40% income tax + USC effective ~48-52% top marginal. India comp moderately competitive post-tax for senior seats (similar to Japan but less extreme).

How does the Dublin EU HQ rotation pipeline shape India MD mandate flow?

Substantially and predictably. Dublin's EU HQ density at FAANG and Fortune-100 captives — Google Dublin (~9,000 employees, EMEA HQ), Meta Dublin (~6,000), LinkedIn Dublin, Microsoft Dublin Sandyford, Salesforce Dublin, Workday Dublin — creates a structured parent-region rotation source for India MD seats. Senior Indian-origin product / engineering / programme-management directors at Dublin EU HQ typically rotate to India MD bench on 2-3 year horizons. The pattern is structurally similar to Singapore Asia HQ rotation (where Indian-origin Singapore senior leaders rotate to India MD seats) but with Dublin as parent-region for EU + global products. Distinctive corridor advantages: (a) Indian Embassy Dublin actively coordinates India-Ireland tech mobility under India-Ireland Strategic Partnership 2023; (b) Stamp 4 PR after 21 months on CSEP creates flexible base-retention for partial-return scenarios; (c) Dublin-EU-HQ + Bangalore-Hyderabad-India-captive parent-region cohesion is the most-structured in the FAANG ecosystem outside the US west coast. Senior leaders with prior Dublin EU HQ + India interface rotation are top-shortlisted for FAANG / Fortune-100 India MD succession.

How does the Cork pharma + Galway medtech cluster translate to Indian listed-pharma / medtech CEO seats?

Cleanly and with distinctive parent-region rotation credentials. Cork pharma cluster — Pfizer Cork (Pfizer's largest manufacturing site outside US — sterile injectable + API + finished-dose), Eli Lilly Kinsale (second-largest Lilly manufacturing globally — oncology + diabetes pipeline), AbbVie Cork (large AbbVie API + finished-dose — immunology + oncology) — is one of Europe's densest pharma manufacturing clusters. Senior Indian-origin commercial and operating leadership at Cork pharma facilities is routinely placed at: (a) Direct parent India MD seats — Pfizer India MD, Eli Lilly India MD, AbbVie India MD; (b) Indian listed-pharma CEO bench at Sun Pharma, Dr Reddy's, Cipla, Lupin, Aurobindo, Glenmark — particularly for senior leaders with USFDA-inspection-cycle expertise and sterile-manufacturing operating depth. Galway medtech (Medtronic Galway — largest Medtronic R&D + manufacturing globally outside US, Boston Scientific Galway) translates similarly to Medtronic India MD, Boston Scientific India MD, plus Indian listed-medtech (Poly Medicure, Healthium, Skanray). The Cork Pharma Corridor widget above documents six Cork / Galway entities with their Indian destination map.

What's the tax arithmetic between Irish taxed comp and Indian taxed comp?

Ireland's progressive tax structure — 20% income tax up to ~€42K, 40% above; plus Universal Social Charge (USC) on top of income tax — effectively 48-52% top marginal rate on senior comp. This is meaningfully higher than US (~37% federal + state effective ~45%), Singapore (22% top), or any Gulf zero-tax regime, but lower than UK (45% + NI) and Japan (~50-55%). The Irish corporate tax is famously 12.5% — this is what draws MNC EU HQs to Dublin (not the personal tax break). A typical mid-senior Ireland role at €150K (~₹1.4 cr) produces ~₹75-80L post-tax (~50% effective at top marginal). At €250K (~₹2.3 cr), post-tax is ~₹1.15-1.2 cr. At €400K+ (~₹3.7 cr+), post-tax is ~₹1.85-1.9 cr. India comp becomes economically competitive post-tax at moderate Indian-offer thresholds — a ₹3-4 cr pre-tax India role (~₹2.1-2.8 cr post-tax) dominates a €250K Ireland role post-tax. Senior leaders with ESOP / long-cycle equity overlay at the Indian destination further compound the post-tax advantage. The arithmetic is structurally similar to Japan but less extreme (Japan top marginal ~50-55% effective vs Ireland 48-52%).

How does the CSEP → Stamp 4 → citizenship pathway affect India-return decisions?

Ireland offers one of the EU's most-flexible work-visa-to-PR pathways. The Critical Skills Employment Permit (CSEP) is the fast-track tech / pharma senior-leader pathway — no labour-market test required for salaries above €38K (eased threshold), employer-sponsored but employer-portable (no 12-month lock-in like Germany Blue Card). Stamp 4 PR after 21 months on CSEP — meaningfully faster than Germany Blue Card (33-month route to PR) or UK Skilled Worker route (5-year route to ILR). Citizenship after 5 years total residency — yielding an EU passport, which preserves multi-decade base-retention optionality and reverse-mobility insurance. Implications for India-return decisions: (a) Stamp 4 PR holders have meaningfully more flexibility than CSEP-only holders — Stamp 4 permits multi-month absence with periodic re-entry, similar to UAE Golden Visa or US Green Card with re-entry permit; (b) Citizenship + EU passport creates structural reverse-mobility insurance — Irish citizenship holders can return to Ireland (and broader EU) for advisory / board / non-executive engagements while pursuing India CEO seats; (c) The 21-month CSEP → Stamp 4 cycle is structurally shorter than other EU pathways, making Ireland the most-flexible base-retention EU geography for India-return optionality.

How early should an Ireland-based NRI start the India-return planning?

9-12 months is the standard pre-positioning window for an Ireland-based Indian senior executive targeting a CEO seat in India — shorter than US (18 months), Japan (12-15 months), and structurally similar to UK / Singapore (9-12 months). The shorter window is calibrated to several corridor-specific dynamics: Dublin's compact business-network density makes informal trust-build operationally easier than US / Japan; the India-Ireland Strategic Partnership 2023 has accelerated bilateral senior-leadership mobility; Dublin EU HQ rotation cycles operate on shorter timelines (typically 6-18 months internal nemawashi vs Japan's 6-9 months); CSEP → Stamp 4 + Irish citizenship pathway provides flexible reverse-mobility insurance. The 9-12 months breaks down as: months 1-3 informal trust-build (India-Ireland Business Association, FICCI / CII Ireland-chapter events, Embassy of India Dublin industry engagement, India-Ireland Strategic Partnership programs, deliberate India business-travel cadence — Mumbai BKC, Bangalore, Hyderabad industry visits); months 4-7 active mandate exploration via discreet channels (named retained firms — Egon Zehnder Dublin, Spencer Stuart Dublin, Heidrick Dublin, Korn Ferry Dublin, plus India-only retained firms with Dublin-corridor scope); months 8-12 internal Dublin EU HQ consensus-build + Irish-onboarding-exit + family relocation + India onboarding. Compressing below 7 months consistently produces sub-optimal outcomes on Dublin EU HQ internal rotation cycles.

How does the India-Ireland Strategic Partnership 2023 affect the corridor outlook?

Substantially. The India-Ireland Strategic Partnership was formalised in 2023 — formalising India-Ireland bilateral cooperation across education, technology, pharma, R&D, and senior-leadership mobility. Indian Embassy Dublin actively coordinates India-Ireland tech mobility under this partnership. Implications for the corridor: (a) Faster work-visa processing for Indian-origin Ireland candidates via DETE Ireland (Department of Enterprise, Trade and Employment) under the partnership framework; (b) Bilateral business-network calendar — India-Ireland Business Association annual summit, India-Ireland Strategic Partnership anniversary cycles (Dublin and Delhi rotating), pharma / tech / R&D bilateral working-group events; (c) Indian listed-pharma + Irish-pharma JV growth (Sun Pharma-Ireland operations, Dr Reddy's Ireland presence, Cipla Ireland) — generating downstream Indian listed-pharma + Ireland-pharma platform-CEO mandate flow; (d) Indian listed-tech + Irish-tech JV growth (Tata Group Ireland, Infosys Dublin, TCS Dublin, Wipro Dublin) — generating downstream Indian listed-tech + Ireland-tech platform-CEO mandate flow. Senior Ireland-resident Indian executives positioning for the post-2023 partnership-driven mobility window should consider 2026-2027 the optimal pre-positioning years.

Are Indian listed family-business CEO seats accessible from an Ireland base?

Yes, with corridor-specific dynamics. Indian family-led conglomerates (Tata, Mahindra, Birla, Bajaj, Godrej, Adani) increasingly recruit Ireland-resident Indian-origin senior leaders for distinct reasons. (a) Tata Group has explicit Ireland operations (Tata Consultancy Services Dublin, Tata Steel Europe-adjacent operations) — Indian-origin Tata Dublin senior leadership rotates to Tata Group India platform-CEO bench. (b) Indian listed-pharma family-businesses (Sun Pharma — Dilip Shanghvi family, Cipla — Hamied family, Lupin — Gupta family, Dr Reddy's — Reddy family) actively recruit Cork pharma cluster senior leaders for plant-president and commercial-leadership succession. (c) Indian listed-tech founder-family-businesses (TCS — Tata family, Infosys — Murthy family adjacency, Wipro — Premji family) recruit Dublin EU HQ FAANG senior bench. (d) Cork / Galway senior pharma operating leadership translates to Indian family-business pharma succession at Aurobindo (Penaka Reddy family), Glenmark (Saldanha family), and Torrent Pharma (Sudhir Mehta family). Boards filter for genuine return commitment — partial-return arrangements (which the Stamp 4 + Irish-citizenship pathway makes structurally easier than other corridors) work best for advisory / board / non-executive engagements, not full-time CEO seats.

Begin

The Ireland-to-India return uses Dublin EU HQ rotation as parent-region cohesion source.

Dublin EU HQ / Cork-pharma / Apple-Cork credential framing, CSEP → Stamp 4 → citizenship sequencing, EUR-INR post-tax modelling, FAANG India MD pipeline mandate flow, Cork → Indian-pharma translation — solved simultaneously, not sequentially. A 20-minute private intake, an integrated Ireland-corridor brief within 7 days, and your first encrypted Dublin-EU-HQ/Cork-pharma-credential + India-CEO + Stamp-4-timing briefing within 14 days.